Sign in
4

Changes in Ownership

Harmony Biosciences Holdings, Inc. Filed Acc 0001104659-22-042846

Chief Commercial Officer sold 14,471 shares at an average $49.63 ($718,170)

  • Chief Commercial Officer acquired 14,471 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Dierks Jeffrey · Chief Commercial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-04-01 Exercise or conversion : show line 1 in the form +14,471 $24.00 $347,304 14,471 D
2022-04-01 Sale : show line 2 in the form −6,765 $49.36 $333,893 7,706 D
2022-04-01 Sale : show line 3 in the form −7,706 $49.87 $384,277 0 D
Open-market sales · 14,471 sh · avg $49.63 · $718,170

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-04-01 Exercise or conversion : show line 4 in the form Stock Option −14,471 116,085 D
Loading xslF345X03/tm2211710-1_4seq1.xml…